Cargando…

Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study

BACKGROUND: Crohn's disease (CD) and multiple sclerosis (MS) share common pathogenic processes. Interferon (IFN) beta-1a is effective and generally well tolerated in patients with MS and has been shown to down-regulate the expression of interleukin-12, a cytokine that is thought to be involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pena Rossi, Claudia, Hanauer, Stephen B, Tomasevic, Ratko, Hunter, John O, Shafran, Ira, Graffner, Hans
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674451/ https://www.ncbi.nlm.nih.gov/pubmed/19302707 http://dx.doi.org/10.1186/1471-230X-9-22

Ejemplares similares

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn’s disease
por: Laffin, Michael R., et al.
Publicado: (2018)

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
por: Wu, Kai-Chun, et al.
Publicado: (2016)

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration
por: Kuenzig, M Ellen, et al.
Publicado: (2018)

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study
por: Schulman, Jacqueline M., et al.
Publicado: (2017)

Endoscopic activity, tissue factor and Crohn’s disease: findings in clinical remission patients
por: Andrade, Adriana Ribas, et al.
Publicado: (2020)

Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis
por: Hashash, Jana G., et al.
Publicado: (2021)

Lactobacillus GG in inducing and maintaining remission of Crohn's disease
por: Schultz, Michael, et al.
Publicado: (2004)

Crohn’s disease in remission or simply smouldering?
por: Gaya, Daniel R.
Publicado: (2015)

The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
por: Bergsagel, D. E., et al.
Publicado: (1990)

Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn’s disease
por: Wu, Jianghong, et al.
Publicado: (2013)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn’s Disease: a Pilot Randomized Placebo-Controlled Trial
por: Mikocka-Walus, Antonina, et al.
Publicado: (2017)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria
por: Makino, Teruhiko, et al.
Publicado: (2012)

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
por: Landewé, Robert BM, et al.
Publicado: (2020)

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021)

Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease
por: Suzuki, Yasuo, et al.
Publicado: (2016)

Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study
por: Qian, Xiaoxian, et al.
Publicado: (2018)

Correction: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Publicado: (2020)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

CLIPPERS: Induction and maintenance of remission using hydroxychloroquine
por: Tan, Boon Loong, et al.
Publicado: (2015)

Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trial
por: Pontes, Caridad, et al.
Publicado: (2015)

Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn’s disease: a retrospective analysis of 258 patients
por: Kanazawa, Amane, et al.
Publicado: (2013)

Primary Adenocarcinoma of an Ileostomy in Crohn's Disease
por: Liu, Kevin, et al.
Publicado: (2016)

Structural Imaging Changes and Behavioral Correlates in Patients with Crohn’s Disease in Remission
por: Nair, Veena A., et al.
Publicado: (2016)

Alterations in resting-state functional connectivity in patients with Crohn’s disease in remission
por: Hou, Jiancheng, et al.
Publicado: (2019)

CSF-1 regulates the function of monocytes in Crohn’s disease patients in remission
por: Nieto, Juan Camilo, et al.
Publicado: (2017)

Remission in Crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
por: Magro, Daniéla Oliveira, et al.
Publicado: (2019)

Orbital Myositis in a Patient With Ileal Crohn's Disease in Remission on Vedolizumab
por: Sandhu, Sunny, et al.
Publicado: (2022)

Effects of Crohn’s disease exclusion diet on remission: a systematic review
por: Zhu, Zhanhui, et al.
Publicado: (2023)

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease
por: Haskey, Natasha, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
por: Jansen, Fenna M, et al.
Publicado: (2023)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Crohn’s Disease Remission with a Plant-Based Diet: A Case Report
por: Sandefur, Kelsea, et al.
Publicado: (2019)

Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mcfi9ilqvrfkh3gv96ha273hke